Skip to main content
. 2023 Oct 21;13(20):2803. doi: 10.3390/nano13202803

Table 2.

CNPs in inflammatory autoimmune diseases: literature summary.

Nanomaterial Synthesis Method Morphology Size (nm) Model Dosage Route of Administration Markers Effects Ref.
Powder Hydrodynamic Radius
Albumin-conjugated CNPs
(A-CNP)
Biomineralization Spherical 30 ± 8.9 ND DBA/1J mice exposed to collagen-induced arthritis (CIA) mouse as in vivo model for rheumatoid arthritis 1 mg/kg, 2
times a week
Intra-articular injection ↓ iNOS
↑ Arg-1
M2 polarization
↓ clinical score
[39]
THP-1 human monocytes and RAW 264.7 murine macrophages 0.5 μg/mL for 24 h NA ↓ iNOS, IL-1β
↑ Arg-1
↓ HIF-1α
M2 polarization
↑ antioxidant response
↓ hypoxia
Citric-acid-coated CNPs
(CA-CNPs)
Alkaline-based precipitation Spherical 2.8 ± 0.4 3.4 ± 1.1 HepG2 hepatocyte cells,
RAW264.7 murine macrophages, Renca epithelial kidney cells and SVEC4-10EHR1 endothelial cells exposed to LPS or H2O2
0.1–1 mg/mL for 24 h NA ↑ SOD, CAT and HORAC activity
↓ ROS (OH)
↓ TNF-α, IL-1β
↑ cell viability
↓ oxidative stress
↓ inflammation
[40]
C57BL/6J mice treated with complete Freund’s adjuvant (CFA) as in vivo model for peripheral Inflammation 100 mg/kg Intravenous tail injection ↓ TNF-α, IL-1β
↑ IL-10
↓ paw inflammation
↓ edema formation
↓ immune cell infiltration
CNPs + Hyaluronic acid hydrothermal Cubic 10–60 ND Chondrocytes treated with H2O2 for 30 min 0.02 μg/mL NA ↑ ACAN, COL1A1, COL2A1 ↓ cell apoptosis
↓ oxidative stress
↓ glycosaminoglycan synthesis
[42]
CNPs NA Spherical 5 10 Sprague-Dawley-rat-derived chondrocytes treated with IL-1β 160 μg/mL NA ↓ ROS (O2)
↓ NO
↑ Nrf2, HO-1, SOD, CAT, GPX
↑ ACAN, COL1A1, COL2A1
↓ MMP13, ADAMTS4
↓iNOS, COX-2, IL-6
↓ oxidative stress
↑ antioxidant response
↓ cell apoptosis
↓ ECM degradation
↓ inflammation
[43]
Sprague-Dawley-rat-derived condylar cartilage explants treated with IL-1β ↓ ROS (O2)
↓ NO
↓ apoptosis
↓oxidative stress
CNPs + Lenalidomide Precipitation Spherical 3–5 34 ± 6.8 C57BL/6 mice treated with MOG 35–55 peptide and pertussis toxin (experimental autoimmune encephalomyelitis) as in vivo model for multiple sclerosis (MS) 1 mg/kg, every fourth day Intravenous injection ↑ MBP
↓ TNF-α
↓ IL-17, INF-γ, TNF-α (mRNA)
↓ GFAP, Iba-1
↓ CD86+ dendritic cells
↓ clinical score
↑ body weight
↓ ventricular volume
↓ myelin loss
↓ inflammation
↓ glial cell activation
↓ peripheral immune reaction
[45]

CNPs: cerium oxide nanoparticles; iNOS: inducible nitric oxide synthase; M1/2: macrophage 1/2; Arg-1: arginase-1; HIF-1α: hypoxia inducible factor-1 alpha; SOD: superoxide dismutase; CAT: catalase; HORAC: hydroxyl radical antioxidant capacity (HORAC) assay; ROS: reactive oxygen species; IL: interleukin; MBP: myelin basic protein; INF-γ: interferon gamma; TNF-α: tumor necrosis factor-alpha; GFAP: glial fibrillary acidic protein; Iba-1: ionized calcium-binding adapter molecule 1; ACAN: aggrecan; COL: collagen; NO: nitrite; HO-1: heme oxygenase 1; GPX: glutathione peroxidase; MMP: matrix metallopeptidase; ADAMTS4: metallopeptidase with thrombospondin type 1 motif 4; COX: cyclooxygenase; ECM: extracellular matrix; Nrf2: nuclear factor erythroid 2-related factor 2; ND: not determined; NA: not applicable. Colored areas highlight in vivo experiments.